James received his PhD in Immunology from the University of Connecticut and have published extensively in the field of applied immunology using immuno-microarrays in combination with surface plasmon based detection systems. His recent work has focused on the regulation of zinc signaling in the context of CD4 T cell effector cell development and adaptive immune responses. He is currently collaborating on a nanoparticle vaccine study to evaluate the immune responses to nanoparticle delivered peptide or mRNA based vaccines in controlling tumor growth in animal models of lymphoma and prostate cancer.